| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CRBU sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 14, 2025 | Haurwitz Rachel E. | President And CEO | Buy | 20,000 | $1.02 | $20,400.00 | +0.6% | +14.9% | +86.1% | |
| Feb 21, 2025 | McClung Barbara G | Chief Legal Officer | Sell | 3,564 | $1.35 | $4,811.40 | -0.8% | -16.4% | +37.4% | |
| Feb 21, 2025 | Khan Ruhi Ahmad | Chief Business Officer | Sell | 3,564 | $1.35 | $4,811.40 | -5.1% | -16.4% | +37.4% | |
| Feb 21, 2025 | Kanner Steven | Chief Scientific Officer | Sell | 3,564 | $1.35 | $4,811.40 | -0.8% | -16.4% | +37.4% | |
| Jan 29, 2025 | Ryali Sriram | Chief Financial Officer | Buy | 17,360 | $1.42 | $24,651.20 | New | -36.4% | +10.4% | |
| Jan 19, 2023 | Rizvi Syed Ali-Aamir | Chief Medical Officer | Sell | 5,627 | $6.31 | $35,506.37 | -8.7% | -29.3% | -18.6% | |
| Oct 6, 2022 | Fischesser Ryan | VP Of Finance And Controller | Sale+OE | 10,000 | $10.80 | $107,958.00 | -8.3% | -34.8% | -58.4% | |
| Aug 25, 2022 | Kanner Steven | Chief Scientific Officer | Sale+OE | 43,248 | $11.22 | $485,220.94 | -12.5% | -22.0% | -44.5% | |
| Jan 11, 2022 | Fischesser Ryan | VP Of Finance And Controller | Buy | 7,387 | $4.00 | $29,552.59 | +7.3% | -38.7% | -46.4% | |
| Dec 20, 2021 | Fischesser Ryan | VP Of Finance And Controller | Buy | 1,136 | $2.69 | $3,055.84 | +1.1% | -39.6% | -56.2% |